Literature DB >> 12360853

[Epidemiological studies on aging in France: from the PAQUID study to the Three-City study].

Annick Alpérovitch1, Philippe Amouyel, Jean-François Dartigues, Pierre Ducimetière, Bernard Mazoyer, Karen Ritchie, Christophe Tzourio.   

Abstract

Follow-up of cohorts recruited in general population with active screening and diagnosis of incident cases, is the most appropriate epidemiological design for studying incidence and risk factors of Alzheimer disease and other types of dementia. In France, people considered in the PAQUID study, then in the EVA study, have been the first cohorts on dementia. They have prepared the way for the Three-City (3C) study, conducted in Bordeaux, Dijon and Montpellier. About 9500 persons aged 65 years and over have been recruited in these three cities and will be followed-up during four years. The main objective of the 3C study is to investigate the relation between vascular risk and neurodegenerative diseases. The 3C study will provide essential data for defining strategies for dementia prevention. To measure the impact of the strategies on the incidence of dementia and the social burden of this disease will be an important public health objective in the near future.

Entities:  

Mesh:

Year:  2002        PMID: 12360853     DOI: 10.1016/s1631-0691(02)01476-2

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  10 in total

1.  An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases.

Authors:  Pauline Maillard; Nicolas Delcroix; Fabrice Crivello; Carole Dufouil; Sebastien Gicquel; Marc Joliot; Nathalie Tzourio-Mazoyer; Annick Alpérovitch; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroradiology       Date:  2007-10-16       Impact factor: 2.804

2.  Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly.

Authors:  Pauline Maillard; Fabrice Crivello; Carole Dufouil; Nathalie Tzourio-Mazoyer; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroradiology       Date:  2009-01-13       Impact factor: 2.804

3.  Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults.

Authors:  Patrick J Bernier; Christian Gourdeau; Pierre-Hugues Carmichael; Jean-Pierre Beauchemin; René Verreault; Rémi W Bouchard; Edeltraut Kröger; Robert Laforce
Journal:  CMAJ       Date:  2017-12-04       Impact factor: 8.262

4.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

5.  Improving data availability for brain image biobanking in healthy subjects: Practice-based suggestions from an international multidisciplinary working group.

Authors:  Susan D Shenkin; Cyril Pernet; Thomas E Nichols; Jean-Baptiste Poline; Paul M Matthews; Aad van der Lugt; Clare Mackay; Linda Lanyon; Bernard Mazoyer; James P Boardman; Paul M Thompson; Nick Fox; Daniel S Marcus; Aziz Sheikh; Simon R Cox; Devasuda Anblagan; Dominic E Job; David Alexander Dickie; David Rodriguez; Joanna M Wardlaw
Journal:  Neuroimage       Date:  2017-02-14       Impact factor: 6.556

6.  Early detection of memory impairment in people over 65 years old consulting at Health Examination Centers for the French health insurance: the EVATEM protocol.

Authors:  Christiane Vannier-Nitenberg; Virginie Dauphinot; Bienvenu Bongue; Catherine Sass; Isabelle Rouch; Olivier Beauchet; Pierre Krolak-Salmon; Bruno Fantino
Journal:  BMC Geriatr       Date:  2013-06-06       Impact factor: 3.921

7.  Longitudinal assessment of global and regional rate of grey matter atrophy in 1,172 healthy older adults: modulation by sex and age.

Authors:  Fabrice Crivello; Nathalie Tzourio-Mazoyer; Christophe Tzourio; Bernard Mazoyer
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

8.  Sex-related and tissue-specific effects of tobacco smoking on brain atrophy: assessment in a large longitudinal cohort of healthy elderly.

Authors:  Quentin Duriez; Fabrice Crivello; Bernard Mazoyer
Journal:  Front Aging Neurosci       Date:  2014-11-03       Impact factor: 5.750

9.  How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.

Authors:  Stéphane Epelbaum; Claire Paquet; Jacques Hugon; Julien Dumurgier; David Wallon; Didier Hannequin; Thérèse Jonveaux; Annick Besozzi; Stéphane Pouponneau; Caroline Hommet; Frederic Blanc; Laetitia Berly; Adrien Julian; Marc Paccalin; Florence Pasquier; Julie Bellet; Claire Boutoleau-Bretonniere; Thiphaine Charriau; Olivier Rouaud; Olivier Madec; Aurélie Mouton; Renaud David; Samir Bekadar; Roxane Fabre; Emmanuelle Liegey; Walter Deberdt; Philippe Robert; Bruno Dubois
Journal:  BMJ Open       Date:  2019-06-24       Impact factor: 2.692

10.  Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study.

Authors:  Qiang Luo; Qiang Chen; Wenjia Wang; Sylvane Desrivières; Erin Burke Quinlan; Tianye Jia; Christine Macare; Gabriel H Robert; Jing Cui; Mickaël Guedj; Lena Palaniyappan; Ferath Kherif; Tobias Banaschewski; Arun L W Bokde; Christian Büchel; Herta Flor; Vincent Frouin; Hugh Garavan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Eric Artiges; Marie-Laure Paillère-Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Luise Poustka; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Joseph H Callicott; Venkata S Mattay; Zdenka Pausova; Jean-François Dartigues; Christophe Tzourio; Fabrice Crivello; Karen F Berman; Fei Li; Tomáš Paus; Daniel R Weinberger; Robin M Murray; Gunter Schumann; Jianfeng Feng
Journal:  JAMA Psychiatry       Date:  2019-04-01       Impact factor: 21.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.